Pharmacology, Toxicology and Pharmaceutical Science
Partial Agonist
100%
Carbon 11
98%
Fluorine 18
68%
Retinoid X Receptor
60%
Receptor Agonist
60%
Carboxylate
57%
Mouse
57%
Carbon Dioxide
57%
Tracer
44%
Bexarotene
36%
Neoplasm
28%
Albuminuria
28%
Teratogenicity
28%
Monoclonal Antibody
28%
Pharmaceutical Chemistry
28%
Pet Animal
28%
Pharmacokinetics
28%
Retinoid
28%
Drug Delivery System
28%
2,5-Dimethoxy-4-iodoamphetamine
28%
High Performance Liquid Chromatography
28%
Biodistribution
23%
Malignant Neoplasm
19%
EC50
19%
Side Effect
14%
Nicotinic Acid
14%
Pharmaceutics
14%
Biliary Excretion
14%
Formate
14%
KK-Ay Mouse
14%
Nanoparticle
9%
Breast Cancer
9%
Carcinoma in Situ
9%
Central Nervous System Disease
9%
Disease
8%
Therapeutic Effect
8%
Infusorial Earth
7%
Triphenylphosphine
7%
Hexane
7%
Triazole
7%
Cutaneous T Cell Lymphoma
6%
Lipophilicity
6%
Double Stranded DNA Antibody
5%
Immunoglobulin G2a
5%
Cytarabine
5%
Lymphadenopathy
5%
Lupus Erythematosus Nephritis
5%
Cytokine
5%
Chemokine
5%
Keyphrases
Liver
33%
In Vivo Distribution
28%
Self-forming
28%
Angiogenesis
28%
β2-glycoprotein I (β2GPI)
28%
Pharmacokinetic Differences
28%
Precursor Emissions
28%
Transferability
28%
18F-labeled
28%
Discrete-time Markovian Arrival Process (D-MAP)
28%
Ugi Four-component Reaction
28%
Positron Emission Tomography
28%
Tumor Xenograft
28%
Fetal Transfer
28%
Partial Agonist
28%
Hydroxyaldehydes
28%
Fluorine-18
28%
Zirconium-89 (89Zr)
28%
Cynomolgus Macaque
28%
Labeled Antibody
28%
Positron Emission Tomography Tracers
23%
Tumor-like Lesions
19%
Plasmin
19%
Tube Formation
19%
Vascular Endothelial Growth Factor
19%
Fibrinolysis
19%
PET Imaging
19%
Coagulation
19%
Cleavage Site
19%
Kidney
19%
Baboon
14%
Concomitant Administration
14%
Low Lipophilicity
14%
Blood Concentration
14%
Binding Ability
14%
Lipophilicity
14%
Non-specific Binding
14%
Non-radioactive
14%
Brain-inspired
14%
Enantiopurity
14%
Receptor Agonist
14%
Retinoid X Receptor
14%
Hydroformylation
14%
Cutaneous T-cell Lymphoma
14%
Brain Uptake
14%
Bexarotene
14%
HPLC System
11%
PET Tracer
11%
Human Umbilical Vein Endothelial Cells (HUVECs)
9%
Xenograft
9%
Medicine and Dentistry
Tumor Xenograft
28%
Glycoprotein
28%
Angiogenesis
28%
Nuclear Medicine
28%
Induced Pluripotent Stem Cell
28%
Cardiac Muscle Cell
28%
Cell Proliferation
17%
Fibrinolysis
14%
Fibrinolysin
14%
Vasculotropin A
14%
Positron Emission Tomography
14%
Neoplasm
14%
Extracellular Trap
11%
Xenograft
7%
Antiangiogenic
7%
Tumor Cell
7%
Endothelial Cell
7%
Human Umbilical Vein Endothelial Cell
7%
Pancreas Tumor
7%
Amino Terminal Sequence
7%
Infusorial Earth
5%
Triphenylphosphine
5%
Triazole
5%
Complement Deposition
5%
Iodine 125
5%
Engraftment
5%
Single Photon Emission Computed Tomography-Computed Tomography
5%